• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchNymox Pharmaceutical
    Picture of Nymox Pharmaceutical logo

    NYMXF — Nymox Pharmaceutical Share News

    $0.060.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    • Market Cap
      $6.30m
    • Enterprise Value
      $6.23m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • NYMXF Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    NYMXF Dividends
    • Brief: Nymox Pharmaceutical files for mixed shelf of up to $12 mln

      14/07/2015 22:06
    • Brief: Nymox Pharmaceutical appoints Erik Danielsen as CFO

      13/07/2015 18:15
    • Brief: Nymox Pharmaceutical Q1 earnings per share $0.04

      15/05/2015 22:32
    • Brief: Nymox Pharmaceutical announces new prostate cancer clinical trial results

      20/04/2015 15:00
    • Brief: Nymox announces phase 3 BPH studies

      01/04/2015 15:00
    • Brief: Nymox Q3 shr loss $0.02

      14/11/2014 15:00
    Previous1234Next

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.